MARKET

ADGM

ADGM

Adagio Medical
NASDAQ
1.000
+0.010
+1.01%
After Hours: 1.001 +0.001 +0.06% 19:16 03/04 EST
OPEN
1.000
PREV CLOSE
0.9900
HIGH
1.020
LOW
0.9901
VOLUME
13.31K
TURNOVER
--
52 WEEK HIGH
2.870
52 WEEK LOW
0.6250
MARKET CAP
21.18M
P/E (TTM)
-0.2104
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADGM last week (0223-0227)?
Weekly Report · 2d ago
Weekly Report: what happened at ADGM last week (0216-0220)?
Weekly Report · 02/23 09:47
Adagio Medical to Present at TD Cowen Annual Healthcare Conference
Reuters · 02/20 13:00
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference
Barchart · 02/20 07:00
Weekly Report: what happened at ADGM last week (0209-0213)?
Weekly Report · 02/16 09:47
Weekly Report: what happened at ADGM last week (0202-0206)?
Weekly Report · 02/09 09:48
Adagio Medical highlights favorable safety profile in cardiac ablation study
TipRanks · 02/04 14:20
Adagio Medical Announced the Publication of Results From the US Early Feasibility Study Evaluating Ultralow Temperature Cardiac Ablation for Scar-related Ventricular Tachycardia
Benzinga · 02/04 13:10
More
About ADGM
Adagio Medical Holdings, Inc. is a commercial stage medical device company. It is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. It is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.

Webull offers Adagio Medical Holdings Inc stock information, including NASDAQ: ADGM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADGM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADGM stock methods without spending real money on the virtual paper trading platform.